United States of America: Introduced Bill to Prohibit Contracting with Certain Biotechnology Providers (SB 3385)

On 12 April 2023, a Bill to Prohibit Contracting with Certain Biotechnology Providers (S.B. 3385) was introduced to the US Senate. The proposed legislation seeks to prevent federal agencies from entering into contracts with certain biotechnology companies which raise concerns. Furthermore, the Bill intends to prevent the government from engaging in contracts with companies utilising the equipment or services of the mentioned entities. Additionally, it includes provisions restricting the head of an executive agency from using funds to acquire biotechnology equipment or services from companies of concern or from entering, extending, or renewing contracts with such entities.